Researchers at Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland have developed a simple and rapid technique to assess the antibiotic susceptibility of bacterial samples. At present, this is time consuming and inefficient, often leading to disease progression while patients await lab results. This new approach involves a simple optical microscope and a video camera, such as those commonly found in smartphones. The bacteria are loaded into a simple microfluidic device, and then exposed to a given antibiotic.
AI is increasingly being used in healthcare to reduce clinician workloads and improve patient outcomes. AI-driven technologies are helping to automate mundane tasks, freeing up clinicians to focus on more complex clinical decisions. AI-powered tools can also help identify patterns in medical data that can lead to faster diagnoses and better patient outcomes.
GrayMatters Health, a medtech company based in Israel, has developed Prism for PTSD, a self-neuromodulation therapy. The company has identified what they describe as brain-mechanism-specific biomarkers for certain mental disorders. These involve combining fMRI and EEG data. The Prism for PTSD system targets a specific biomarker called amygdala-derived-EFP, which is involved in the fight or flight response, and which can frequently be triggered in those with PTSD.